Senior insider sale
Chief Operating Officer at RAPPORT THERAPEUTICS, INC. — senior position signals high conviction
$403.9K
10K shares
What this filing means
GAULT CHERYL plans to sell 10K shares of RAPPORT THERAPEUTICS, INC. valued at approximately $403.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/30/2026ACC: 0001950047-26-006648
Officer· Chief Operating Officer
Since Mar 2026
10K
Shares to sell
$403.9K
Approx. market value
10K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Founders Shares
N/A
9/5/2024
10KTotal acquired10K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/5/2024 | Founders Shares N/A | 10K | — |
| Total | 10K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
10K
Market value
$403.9K
6/30/2026
Total
Units
10K
Value
$403.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/30/2026 | 10K | $403.9K | NASDAQ | Planned |
| Total | 10K | $403.9K | ||